Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors. Materials and methods: Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1. Results: The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach's alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73). Conclusion: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.
Abstract
Purpose: The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors. Materials and methods: Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1. Results: The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach's alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73). Conclusion: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.
참고문헌 (30)
- 김주영, "Choosing Wisely: The Korean Perspective and Launch of the ‘Right Decision in Cancer Care’ Initiative", Cancer Research and Treatment, 52(3), pp.655~660 (2020), 대한암학회[DOI]
- European Medicines Agency, "Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient–reported outcome (PRO) measures in oncology studies", European Medicines Agency, ~ (2016)
- Aaronson NK, "The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality-of-life instrument for use in international clinical trials in oncology", J Natl Cancer Inst, 85, pp.365~376 (1993)
- Cella DF, "The Functional Assessment of Cancer Therapy scale : development and validation of the general measure", J Clin Oncol, 11, pp.570~579 (1993)
- Sprangers MA, "The European Organization for Research and Treatment of Cancer: approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life", Qual Life Res, 2, pp.287~295 (1993)
- Jensen RE, "United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer", J Clin Oncol, 35, pp.1913~1920 (2017)
- Brenner H, "Long-term survival rates of cancer patients achieved by the end of the 20th century : a period analysis", Lancet, 360, pp.1131~1135 (2002)
- Grande GE, "Quality of life measures(EORTC QLQ-C30 and SF-36)as predictors of survival in palliative colorectal and lung cancer patients", Palliat Support Care, 7, pp.289~297 (2009)
- Ware JE Jr, "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection", Med Care, 30, pp.473~483 (1992)
- Brooks R, "EuroQol : the current state of play", Health Policy, 37, pp.53~72 (1996)
- Wells GA, "Validity of quality of life measurement tools : from generic to disease-specific", J Rheumatol Suppl, 88, pp.2~6 (2011)
- Efthymiadou O, "Health related quality of life aspects not captured by EQ-5D-5L : results from an international survey of patients", Health Policy, 123, pp.159~165 (2019)
- Cella D, "The Patient-Reported Outcomes Measurement Information System(PROMIS)developed and tested its first wave of adult self-reported health outcome item banks : 2005-2008", J Clin Epidemiol, 63, pp.1179~1194 (2010)
- Jensen RE, "Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients", Qual Life Res, 24, pp.2333~2344 (2015)
- Quach CW, "Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study", Qual Life Res, 25, pp.2811~2823 (2016)
- Fayers PM, "The EORTC QLQ-C30 scoring manual" (2001), European Organization for Research and Treatment of Cancer
- Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13, pp.863~868 (2004)
- Ursachi G, "How reliable are measurement scales? External factors with indirect influence on reliability estimators", Procedia Econ Financ, 20, pp.679~686 (2015)
- Hu LT, "Cutoffcriteria for fit indexes in covariance structure analysis : conventional criteria versus new alternatives", Struct Equ Modeling, 6, pp.1~55 (1999)
- Mokkink LB, "The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments : an international Delphi study", Qual Life Res, 19, pp.539~549 (2010)
- Hinkle DE, "Applied statistics for the behavioral sciences" (2003), Houghton Mifflin
- van Kooten JA, "Content validity of the patient-reported outcomes measurement information system sleep disturbance and sleep related impairment item banks in adolescents", Health Qual Life Outcomes, 14, pp.92~ (2016)
- Terwee CB, "Quality criteria were proposed for measurement properties of health status questionnaires", J Clin Epidemiol, 60, pp.34~42 (2007)
- Dobson KS, "The relationship between anxiety and depression", Clin Psychol Rev, 5, pp.307~324 (1985)
- Krueger RF, "Using item response theory to understand comorbidity among anxiety and unipolar mood disorders", Psychol Assess, 13, pp.140~151 (2001)
- Libman E, "Refreshing sleep and sleep continuity determine perceived sleep quality", Sleep Disord, 2016, pp.7170610~ (2016)
- Hartman JD, "Comparing and transforming PROMIS utility values to the EQ-5D", Qual Life Res, 27, pp.725~733 (2018)
- Morrisroe K, "Validity of the workers productivity and activity impairment questionnaire : specific health problem(WPAI : SHP)in patients with systemic sclerosis", Clin Exp Rheumatol, 35(Suppl 106), pp.130~137 (2017)
- HinchcliffME, "Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis", J Rheumatol, 42, pp.64~72 (2015)
- Forrest CB, "Commentary : the patient-reported outcome measurement information system(PROMIS(R))for children and youth : application to pediatric psychology", J Pediatr Psychol, 37, pp.614~621 (2012)
